Mesogastrium Metastasis in Colon Cancer
Recruiting · NCT04980287 · Observational (researchers observe without assigning treatment) · Lead sponsor: Jichao Qin
View the official record on ClinicalTrials.gov →What this trial is about
Complete mesocolic excision is currently recognized as a standard procedure for colon cancer. Controversy remains on the presence of right gastroepiploic mesentery metastasis in patients with colon cancer locating at or close to the hepatic flexure. The investigators design this study in order to define the incidence of mesogastrium metastasis and analyse the safety and surgical outcome in these patients who undergo complete mesocolic excision with right gastroepiploic mesentery resection.
Who can take part
Age range
18 Years to 75 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Age between 18 and 75 years
- American Society of Anesthesiologists (ASA) score I to III
- A biopsy proven histological diagnosis of colorectal carcinoma
- Preoperative staging cT2-4aN0M0 or cTanyN+M0
- tumor located at hepatic flexure or transverse colon close to flexures
- Undergoing complete mesocolic excision with right gastric mesentery resection
- Patients have to be aware of the aim of the trial, and have signed the informed consent.
Exclusion criteria
- Synchronous colorectal carcinoma
- Clinical evidence of metastasis
- History of colorectal cancer or other malignant tumors
- Preoperative staging cT1N0 or cT4bNany
- Emergency procedure
Where it is running
1 location listed.
- Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology - Wuhan, Hubei, China